Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice

Maria E. Balasis, Kara D. Forinash, Y. Ann Chen, William J. Fulp, Domenico Coppola, Andrew D. Hamilton, Jin Q. Cheng, Saïd M. Sebti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice'. Together they form a unique fingerprint.

Medicine & Life Sciences